Equity shares of Avience Biomedicals Ltd. debuted in the stock market on Jun 25, 2026, listing on the NSE SME platform.
IPO Listing Highlights
Exchange: NSE SME | Issue Price: ₹208.00NSE Details
- NSE Symbol: AVIENCE
- Open: ₹395.20
- High: ₹414.95
- Low: ₹395.20
- Close: ₹414.95
Avience Biomedicals Ltd. was listed at ₹395.20 against its issue price of ₹208.00, before closing at ₹414.95. The stock recorded a trading volume of 7,26,000 shares, showing investor participation on the listing day at NSE SME.
IPO Bidding Snapshot
The IPO of Avience Biomedicals Ltd. was priced at ₹196 to ₹208 per share and comprised a fresh issue of 14,53,800 equity shares aggregating to ₹30.24 crore.
The issue was subscribed 270.19 times overall, with:
- QIBs: 196.77x
- NIIs: 597.23x
- Retail Investors: 401.36x
IPO Managers
The issue was managed by Fintellectual Corporate Advisors Pvt.Ltd. as the Book Running Lead Manager.
